US2009258948A1PendingUtilityA1
Pharmaceutical salts
Est. expiryFeb 28, 2021(expired)· nominal 20-yr term from priority
A61P 25/00A61P 29/00A61K 9/0056A61P 13/00C07D 489/04C07C 215/64C07C 217/68C07B 2200/07A61K 9/0095C07D 275/06A61K 9/0058C07C 2601/14C07D 291/06C07C 215/62C07C 217/74C07C 215/54
67
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to pharmaceutical salts comprised of a pharmaceutical active substance and of at least one sugar substitute, to medicaments containing these salts, and to the use of these salts for producing medicaments.
Claims
exact text as granted — not AI-modified1 .- 39 . (canceled)
40 . A pharmaceutical salt of a salt-forming pharmaceutical active compound and at least one salt-forming sugar substitute, wherein the salt-forming pharmaceutical active compound is a salt-forming 1-phenyl-3-dimethylaminopropane compound selected from the group consisting of: (a) (−)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol; (b) (1RS,3RS,6RS)-6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol; and (c) (−)-(1R,2R)-3-(2-Dimethylaminomethyl-cyclohexyl)-phenol.
41 . The pharmaceutical salt according to claim 40 , wherein the salt-forming pharmaceutical active compound is (−)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol.
42 . The pharmaceutical salt according to claim 40 , wherein the salt-forming pharmaceutical active compound is (1RS,3RS,6RS)-6-Dimethylaminomethyl-1-(3-methoxyphenyl)-cyclohexane-1,3-diol.
43 . The pharmaceutical salt according to claim 40 , wherein the salt-forming pharmaceutical active compound is (−)-(1R,2R)-3-(2-Dimethylaminomethyl-cyclohexyl)-phenol.
44 . A pharmaceutical composition comprising a therapeutically effective amount of the pharmaceutical salt according to claim 40 and optionally one or more physiologically tolerable excipients.
45 . A method of controlling pain comprising administering to a patient in need thereof a pain-controlling effective amount of the pharmaceutical salt of claim 40 .
46 . A method of controlling urinary incontinence comprising administering to a patient in need thereof an urinary incontinence-controlling effective amount of the pharmaceutical salt of claim 40 .Join the waitlist — get patent alerts
Track US2009258948A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.